BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16214062)

  • 1. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications.
    Abmayr S; Weydt P
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):1091-7, xi-xii. PubMed ID: 16214062
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.
    Gonzalez de Aguilar JL; Niederhauser-Wiederkehr C; Halter B; De Tapia M; Di Scala F; Demougin P; Dupuis L; Primig M; Meininger V; Loeffler JP
    Physiol Genomics; 2008 Jan; 32(2):207-18. PubMed ID: 18000159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
    Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
    Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of environmental enrichment on the amyotrophic lateral sclerosis mouse model.
    Sorrells AD; Corcoran-Gomez K; Eckert KA; Fahey AG; Hoots BL; Charleston LB; Charleston JS; Roberts CR; Markowitz H
    Lab Anim; 2009 Apr; 43(2):182-90. PubMed ID: 19246505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of amyotrophic lateral sclerosis.
    Mitsumoto H; Pioro EP
    Adv Neurol; 1995; 68():73-87; discussion 89-91. PubMed ID: 8787246
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
    Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
    Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Dalle-Donne I
    Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative compound muscle action potential: con.
    Dengler R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S105-7. PubMed ID: 12396825
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicine. A reinnervating microRNA.
    Brown RH
    Science; 2009 Dec; 326(5959):1494-5. PubMed ID: 20007892
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there mitochondrial dysfunction in amyotrophic lateral sclerosis skeletal muscle?
    Vielhaber S; Kudin A; Winkler K; Wiedemann F; Schröder R; Feistner H; Heinze HJ; Elger CE; Kunz WS
    Ann Neurol; 2003 May; 53(5):686-7; author reply 687-8. PubMed ID: 12731009
    [No Abstract]   [Full Text] [Related]  

  • 16. Motor unit number estimation: pro.
    Gooch CL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S93-4. PubMed ID: 12396821
    [No Abstract]   [Full Text] [Related]  

  • 17. Motor unit number estimation: con.
    Bromberg MB
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S95. PubMed ID: 12396822
    [No Abstract]   [Full Text] [Related]  

  • 18. Motor unit number estimation: summary.
    Shefner JM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S97-102. PubMed ID: 12396823
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis and the neuroprotective potential of exercise.
    Kiernan MC
    J Physiol; 2009 Aug; 587(Pt 15):3759-60. PubMed ID: 19648444
    [No Abstract]   [Full Text] [Related]  

  • 20. Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials.
    Rothstein JD
    Ann Neurol; 2003 Apr; 53(4):423-6. PubMed ID: 12666108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.